|
1
|
Hall SF, Groome PA, Irish J and O'Sullivan
B: The natural history of patients with squamous cell carcinoma of
the hypopharynx. Laryngoscope. 118:1362–1371. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chung EJ, Lee SH, Baek SH, Park IS, Cho SJ
and Rho YS: Pattern of cervical lymph node metastasis in medial
wall pyriform sinus carcinoma. Laryngoscope. 124:882–887. 2014.
View Article : Google Scholar
|
|
3
|
Lee MS, Ho HC, Hsiao SH, Hwang JH, Lee CC
and Hung SK: Treatment results and prognostic factors in locally
advanced hypopharyngeal cancer. Acta Otolaryngol. 128:103–109.
2008. View Article : Google Scholar
|
|
4
|
Chan JY and Wei WI: Current management
strategy of hypopharyngeal carcinoma. Auris Nasus Larynx. 40:2–6.
2013. View Article : Google Scholar
|
|
5
|
Zhou L: Standardization of the management
of laryngeal and hypopharyngeal carcinoma. Zhonghua Er Bi Yan Hou
Tou Jing Wai Ke Za Zhi. 44:705–706. 2009.In Chinese.
|
|
6
|
Curmi PA, Gavet O, Charbaut E, Ozon S,
Lachkar-Colmerauer S, Manceau V, Siavoshian S, Maucuer A and Sobel
A: Stathmin and its phosphoprotein family: General properties,
biochemical and functional interaction with tubulin. Cell Struct
Funct. 24:345–357. 1999. View Article : Google Scholar
|
|
7
|
Gupta KK, Li C, Duan A, Alberico EO, Kim
OV, Alber MS and Goodson HV: Mechanism for the
catastrophe-promoting activity of the microtubule destabilizer
Op18/stathmin. Proc Natl Acad Sci USA. 110:20449–20454. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nemunaitis J: Stathmin 1: A protein with
many tasks. New biomarker and potential target in cancer. Expert
Opin Ther Targets. 16:631–634. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Wang L, Li T, You B, Shan Y, Shi S,
Qian L and Cao X: STMN1 overexpression correlates with biological
behavior in human cutaneous squamous cell carcinoma. Pathol Res
Pract. 211:816–823. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
11
|
Acloque H, Adams MS, Fishwick K,
Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions:
The importance of changing cell state in development and disease. J
Clin Invest. 119:1438–1449. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kalluri R: EMT: When epithelial cells
decide to become mesenchymal-like cells. J Clin Invest.
119:1417–1419. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hsu HP, Li CF, Lee SW, Wu WR, Chen TJ,
Chang KY, Liang SS, Tsai CJ and Shiue YL: Overexpression of
stathmin 1 confers an independent prognostic indicator in
nasopharyngeal carcinoma. Tumour Biol. 35:2619–2629. 2014.
View Article : Google Scholar
|
|
14
|
Trovik J, Wik E, Stefansson IM,
Marcickiewicz J, Tingulstad S, Staff AC, Njolstad TS, Vandenput I,
Amant F, Akslen LA, et al: MoMaTec Study Group: Stathmin
overexpression identifies high-risk patients and lymph node
metastasis in endometrial cancer. Clin Cancer Res. 17:3368–3377.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuang XY, Chen L, Zhang ZJ, Liu YR, Zheng
YZ, Ling H, Qiao F, Li S, Hu X and Shao ZM: Stathmin and
phospho-stathmin protein signature is associated with survival
outcomes of breast cancer patients. Oncotarget. 6:22227–22238.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nie W, Xu MD, Gan L, Huang H, Xiu Q and Li
B: Overexpression of stathmin 1 is a poor prognostic biomarker in
non-small cell lung cancer. Lab Invest. 95:56–64. 2015. View Article : Google Scholar
|
|
17
|
Tan HT, Wu W, Ng YZ, Zhang X, Yan B, Ong
CW, Tan S, Salto-Tellez M, Hooi SC and Chung MC: Proteomic analysis
of colorectal cancer metastasis: Stathmin-1 revealed as a player in
cancer cell migration and prognostic marker. J Proteome Res.
11:1433–1445. 2012. View Article : Google Scholar
|
|
18
|
Björklund P, Cupisti K, Fryknäs M,
Isaksson A, Willenberg HS, Akerström G, Hellman P and Westin G:
Stathmin as a marker for malignancy in pheochromocytomas. Exp Clin
Endocrinol Diabetes. 118:27–30. 2010. View Article : Google Scholar
|
|
19
|
Ghanim B, Klikovits T, Hoda MA, Lang G,
Szirtes I, Setinek U, Rozsas A, Renyi-Vamos F, Laszlo V, Grusch M,
et al: Ki67 index is an independent prognostic factor in
epithelioid but not in non-epithelioid malignant pleural
mesothelioma: A multicenter study. Br J Cancer. 112:783–792. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Belletti B, Nicoloso MS, Schiappacassi M,
Berton S, Lovat F, Wolf K, Canzonieri V, D'Andrea S, Zucchetto A,
Friedl P, et al: Stathmin activity influences sarcoma cell shape,
motility, and metastatic potential. Mol Biol Cell. 19:2003–2013.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Akhtar J, Wang Z, Zhang ZP and Bi MM:
Lentiviral-mediated RNA interference targeting stathmin1 gene in
human gastric cancer cells inhibits proliferation in vitro and
tumor growth in vivo. J Transl Med. 11:2122013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei SH, Lin F, Wang X, Gao P and Zhang HZ:
Prognostic significance of stathmin expression in correlation with
metastasis and clinicopathological characteristics in human ovarian
carcinoma. Acta Histochem. 110:59–65. 2008. View Article : Google Scholar
|
|
23
|
Singer S, Ehemann V, Brauckhoff A, Keith
M, Vreden S, Schirmacher P and Breuhahn K: Protumorigenic
overexpression of stathmin/Op18 by gain-of-function mutation in p53
in human hepatocarcinogenesis. Hepatology. 46:759–768. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gan L, Guo K, Li Y, Kang X, Sun L, Shu H
and Liu Y: Up-regulated expression of stathmin may be associated
with hepatocarcinogenesis. Oncol Rep. 23:1037–1043. 2010.PubMed/NCBI
|
|
25
|
He X, Liao Y, Lu W, Xu G, Tong H, Ke J and
Wan X: Elevated STMN1 promotes tumor growth and invasion in
endometrial carcinoma. Tumour Biol. 37:9951–9958. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–15642. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu Q, Deng F, Qin Y, Zhao Z, Wu Z, Xing Z,
Ji A and Wang QJ: Long non-coding RNA regulation of
epithelial-mesenchymal transition in cancer metastasis. Cell Death
Dis. 7:e22542016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Przybyla L, Muncie JM and Weaver VM:
Mechanical control of epithelial-to-mesenchymal transitions in
development and cancer. Annu Rev Cell Dev Biol. 32:527–554. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
van Roy F and Berx G: The cell-cell
adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chan SH and Wang LH: Regulation of cancer
metastasis by microRNAs. J Biomed Sci. 22:92015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Park JS, Lee JH, Lee YS, Kim JK, Dong SM
and Yoon DS: Emerging role of LOXL2 in the promotion of pancreas
cancer metastasis. Oncotarget. Jun 7–2016.Epub ahead of print.
View Article : Google Scholar
|
|
33
|
Bloom JE and McNeel DG: SSX2 regulates
focal adhesion but does not drive the epithelial to mesenchymal
transition in prostate cancer. Oncotarget. Jun 2–2016.Epub ahead of
print. PubMed/NCBI
|
|
34
|
Karaczyn AA, Adams TL, Cheng RY, Matluk NN
and Verdi JM: Human NUMB6 induces epithelial-mesenchymal transition
and enhances breast cancer cells migration and invasion. J Cell
Biochem. Jun 15–2016.Epub ahead of print. PubMed/NCBI
|
|
35
|
Lu Y, Liu C, Xu YF, Cheng H, Shi S, Wu CT
and Yu XJ: Stathmin destabilizing microtubule dynamics promotes
malignant potential in cancer cells by epithelial-mesenchymal
transition. Hepatobiliary Pancreat Dis Int. 13:386–394. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li N, Jiang P, Du W, Wu Z, Li C, Qiao M,
Yang X and Wu M: Siva1 suppresses epithelial-mesenchymal transition
and metastasis of tumor cells by inhibiting stathmin and
stabilizing microtubules. Proc Natl Acad Sci USA. 108:12851–12856.
2011. View Article : Google Scholar : PubMed/NCBI
|
